Publications

Therapeutic Areas

Modeling & Meta-Analyses

Newest to Oldest

Cost-effectiveness of a 12-month fixed-duration venetoclax treatment in combination with obinutuzumab in first-line, unfit chronic lymphocytic leukemia in the United States

Authors: A Chatterjee, S Shapouri, BS Manzoor, A Ravelo, K Sail, V Qendri, G van de Wetering, MS Davids

Cost-effectiveness of a 12-month fixed duration of Venetoclax in combination with Obinutuzumab versus chemoimmunotherapy and other novel combinations in first-line chronic lymphocytic leukemia in Canada

Authors: A Chatterjee, G Van de Wetering, R Goeree, A M Desbois, P Manzi, B S Manzoor, C Owen, K Sail

Estimating and extrapolating survival using a state-transition modeling approach: a practical application in multiple myeloma

Authors: I Majer, S Kroep, R Maroun, C Williams, S Klijn, S Palmer

Clinical implications and cost-effectiveness analysis of Rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the Netherlands

Authors: J A Spoorendonk, J-B Briere, K Bowrin, A Millier, M Coppens, S Tempelaar, B Verheggen

Cost effectiveness of Vericiguat for the treatment of chronic heart failure with reduced ejection fraction following a worsening heart failure event from a US Medicare perspective

Authors: Alsumali, A., Djatche, L.M., Briggs, A., Liu, R., Diakite, I., Patel, D., Wang, Y. and Lautsch, D.

Short communication: prevalence of transmitted resistance to non-nucleoside reverse transcriptase inhibitors in European and North American countries over 20 years: an updated meta-analysis

Authors: S J Snedecor

An integrated pharmacokinetic-pharmacodynamic-pharmacoeconomic modeling method to evaluate treatments for adults with schizophrenia

Authors: MA Piena, N Houwing, CW Kraan, X Wang, H Waters, RA Duffy, S Mallikaarjun, C Bennison

Prevalence of transmitted resistance to nonnucleoside reverse transcriptase inhibitors in european and north american countries over 20 years: an updated meta-analysis

Authors: SJ Snedecor

Impact of carbidopa-levodopa enteral suspension on quality of life and activities of daily living in patients with advanced Parkinson's disease: Results from a pooled meta-analysis

Authors: DG Standaert, V Patel, SJ Snedecor, S Thakkar, YJ Jalundhwala, P Kukreja, D Kratochvil, Y Bao, R Pahwa

Budget Impact Analysis of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Event

Authors: A Alsumali, D Lautsch, R Liu, D Patel, S Nanji, LM Djatche

View older